Search
Investors
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Investor FAQs
Contact Us
Investors  >  Press Releases

Press Releases

All Releases
View Summary Enzymotec Ltd. Reports First Quarter 2017 Unaudited Financial Results
May 17, 2017
PDF 47.6 KB Add to Briefcase
View Summary Enzymotec to Report First Quarter 2017 Financial Results
May 3, 2017
PDF 9.8 KB Add to Briefcase
View Summary Neptune and Enzymotec Reach Patent Agreement Ending All Litigation
Apr 3, 2017
PDF 14.7 KB Add to Briefcase
View Summary Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2016
Mar 16, 2017
PDF 10.0 KB Add to Briefcase
View Summary Enzymotec Ltd. Calls an Extraordinary General Meeting of Shareholders
Mar 10, 2017
PDF 14.7 KB Add to Briefcase
View Summary Enzymotec Ltd. Announces the Appointment of Erez Israeli as President and CEO
Mar 9, 2017
PDF 13.7 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports Fourth Quarter and Full Year 2016 Unaudited Financial Results
Feb 22, 2017
PDF 63.3 KB Add to Briefcase
View Summary Enzymotec Ltd. Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results
Feb 6, 2017
PDF 17.0 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports Third Quarter 2016 Unaudited Financial Results
Nov 16, 2016
PDF 61.1 KB Add to Briefcase
View Summary Enzymotec Ltd. Announces Departure of its CEO
Nov 16, 2016
PDF 13.5 KB Add to Briefcase
View Summary Enzymotec to Report Third Quarter 2016 Financial Results
Nov 2, 2016
PDF 9.8 KB Add to Briefcase
View Summary Enzymotec Ltd. Granted New Patents for INFAT® in the U.S., Vayacog® in Japan and Phospholipid-Based Products in Canada and Korea
Sep 27, 2016
PDF 15.1 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports Second Quarter 2016 Unaudited Financial Results
Aug 9, 2016
PDF 60.0 KB Add to Briefcase
View Summary Enzymotec Ltd. To Present at Two Upcoming Investor Conferences
Aug 2, 2016
PDF 8.9 KB Add to Briefcase
View Summary Enzymotec to Report Second Quarter 2016 Financial Results
Jul 26, 2016
PDF 9.8 KB Add to Briefcase
View Summary CORRECTING and REPLACING -- Enzymotec Ltd. Calls its 2016 Annual General Meeting of Shareholders
Jul 13, 2016
PDF 16.8 KB Add to Briefcase
View Summary Enzymotec Ltd. Calls for its 2016 Annual General Meeting of Shareholders
Jul 13, 2016
PDF 15.6 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results
May 19, 2016
PDF 46.8 KB Add to Briefcase
View Summary Enzymotec to Report First Quarter 2016 Financial Results
May 5, 2016
PDF 9.7 KB Add to Briefcase
View Summary Enzymotec Ltd. Granted Patents in U.S. for Compositions and Processes Related to Infant Nutrition and China for INFAT® Uses Promoting Development of Beneficial Gut Flora and Reducing Infant Crying Duration
Mar 29, 2016
PDF 14.3 KB Add to Briefcase
Showing 1-20 of 97 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase
  Home Page | Site Map | Contact Us  
Signed by CDTech - Web Development and Design  
Disclaimer: These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat , cure or prevent disease.
Copyright (©) 2013 Enzymotec Ltd. All rights reserved.